well-tolerated in mice, rats, rabbits, and dogs with no serious organ toxicity.[34][35] Clinical Safety : Mild local irritation possible at injection sites, but no systemic adverse effects reported in trials.[36][37] Potential Risks : Theoretical concerns include pro-angiogenic effects potentially promoting tumor growth, though no evidence supports this in studies.[38] Long-term human data is limited, so monitoring is advised
Its compact structure enables efficient interaction with various biological systems, contributing to its broad therapeutic potential observed in preclinical studies
Changes in Appetite: A few individuals notice increased or decreased appetite, likely linked to gastrointestinal modulation
It is why, at MEGI, we are bringing clinicians, researchers, founders, regulators and investors together for our AI Womens Health summit on 25 June